skip to content
Follow-on biologics : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007. Preview this item
ClosePreview this item
Checking...

Follow-on biologics : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007.

Author: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Publisher: Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008.
Series: United States.; Congress.; Senate.; S. hrg.
Edition/Format:   Print book : National government publication : EnglishView all editions and formats
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Additional Physical Format: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Follow-on biologics
iv, 78 p.
(OCoLC)272396761
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Follow-on biologics
iv, 78 p.
(OCoLC)464618706
Online version:
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Follow-on biologics.
Washington : U.S.G.P.O. : For sale by the Supt. of Docs., U.S.G.P.O., 2008
(OCoLC)657449220
Material Type: Government publication, National government publication, Internet resource
Document Type: Book, Internet Resource
All Authors / Contributors: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
ISBN: 9780160817557 0160817552
OCLC Number: 272403831
Notes: Shipping list no.: 2009-0050-P.
Description: iv, 78 pages ; 24 cm.
Series Title: United States.; Congress.; Senate.; S. hrg.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/272403831> # Follow-on biologics : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007.
    a schema:Book, schema:CreativeWork ;
    library:oclcnum "272403831" ;
    library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/158571627#Place/washington> ; # Washington
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/dcu> ;
    schema:about <http://id.worldcat.org/fast/1204155> ; # United States
    schema:about <http://experiment.worldcat.org/entity/work/data/158571627#Topic/pharmaceutical_biotechnology_government_policy_united_states> ; # Pharmaceutical biotechnology--Government policy--United States
    schema:about <http://experiment.worldcat.org/entity/work/data/158571627#Topic/pharmaceutical_biotechnology_united_states_patents> ; # Pharmaceutical biotechnology--United States--Patents
    schema:about <http://id.loc.gov/authorities/classification/KF26> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/158571627#Topic/pharmaceutical_technology_government_policy_united_states> ; # Pharmaceutical technology--Government policy--United States
    schema:about <http://experiment.worldcat.org/entity/work/data/158571627#Topic/drug_development_government_policy_united_states> ; # Drug development--Government policy--United States
    schema:about <http://id.worldcat.org/fast/1060106> ; # Pharmaceutical biotechnology
    schema:bookFormat bgn:PrintBook ;
    schema:creator <http://viaf.org/viaf/144570807> ; # United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
    schema:datePublished "2008" ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/158571627> ;
    schema:genre "Government publication"@en ;
    schema:genre "National government publication"@en ;
    schema:genre "Patents"@en ;
    schema:inLanguage "en" ;
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/158571627#Series/s_hrg> ; # S. hrg. ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/464618706> ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/657449220> ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/272396761> ;
    schema:name "Follow-on biologics : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007."@en ;
    schema:productID "272403831" ;
    schema:publication <http://www.worldcat.org/title/-/oclc/272403831#PublicationEvent/washington_u_s_g_p_o_for_sale_by_the_supt_of_docs_u_s_g_p_o_2008> ;
    schema:publisher <http://experiment.worldcat.org/entity/work/data/158571627#Agent/for_sale_by_the_supt_of_docs_u_s_g_p_o> ; # For sale by the Supt. of Docs., U.S. G.P.O.
    schema:publisher <http://experiment.worldcat.org/entity/work/data/158571627#Agent/u_s_g_p_o> ; # U.S. G.P.O.
    schema:url <http://purl.access.gpo.gov/GPO/LPS105468> ;
    schema:url <http://purl.access.gpo.gov/GPO/LPS105469> ;
    schema:workExample <http://worldcat.org/isbn/9780160817557> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/272403831> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/158571627#Agent/for_sale_by_the_supt_of_docs_u_s_g_p_o> # For sale by the Supt. of Docs., U.S. G.P.O.
    a bgn:Agent ;
    schema:name "For sale by the Supt. of Docs., U.S. G.P.O." ;
    .

<http://experiment.worldcat.org/entity/work/data/158571627#Agent/u_s_g_p_o> # U.S. G.P.O.
    a bgn:Agent ;
    schema:name "U.S. G.P.O." ;
    .

<http://experiment.worldcat.org/entity/work/data/158571627#Organization/united_states_congress_senate> # United States. Congress. Senate.
    a schema:Organization ;
    schema:name "United States. Congress. Senate." ;
    .

<http://experiment.worldcat.org/entity/work/data/158571627#Series/s_hrg> # S. hrg. ;
    a bgn:PublicationSeries ;
    schema:creator <http://experiment.worldcat.org/entity/work/data/158571627#Organization/united_states_congress_senate> ; # United States. Congress. Senate.
    schema:hasPart <http://www.worldcat.org/oclc/272403831> ; # Follow-on biologics : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007.
    schema:name "S. hrg. ;" ;
    .

<http://experiment.worldcat.org/entity/work/data/158571627#Topic/drug_development_government_policy_united_states> # Drug development--Government policy--United States
    a schema:Intangible ;
    schema:hasPart <http://id.loc.gov/authorities/subjects/sh97007921> ;
    schema:name "Drug development--Government policy--United States"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/158571627#Topic/pharmaceutical_biotechnology_government_policy_united_states> # Pharmaceutical biotechnology--Government policy--United States
    a schema:Intangible ;
    schema:hasPart <http://id.loc.gov/authorities/subjects/sh90004049> ;
    schema:name "Pharmaceutical biotechnology--Government policy--United States"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/158571627#Topic/pharmaceutical_biotechnology_united_states_patents> # Pharmaceutical biotechnology--United States--Patents
    a schema:Intangible ;
    schema:hasPart <http://id.loc.gov/authorities/subjects/sh90004049> ;
    schema:name "Pharmaceutical biotechnology--United States--Patents"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/158571627#Topic/pharmaceutical_technology_government_policy_united_states> # Pharmaceutical technology--Government policy--United States
    a schema:Intangible ;
    schema:hasPart <http://id.loc.gov/authorities/subjects/sh85100590> ;
    schema:name "Pharmaceutical technology--Government policy--United States"@en ;
    .

<http://id.worldcat.org/fast/1060106> # Pharmaceutical biotechnology
    a schema:Intangible ;
    schema:name "Pharmaceutical biotechnology"@en ;
    .

<http://id.worldcat.org/fast/1204155> # United States
    a schema:Place ;
    schema:name "United States" ;
    .

<http://viaf.org/viaf/144570807> # United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
    a schema:Organization ;
    schema:name "United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions." ;
    .

<http://worldcat.org/isbn/9780160817557>
    a schema:ProductModel ;
    schema:isbn "0160817552" ;
    schema:isbn "9780160817557" ;
    .

<http://www.worldcat.org/oclc/272396761>
    a schema:CreativeWork ;
    rdfs:label "Follow-on biologics" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/272403831> ; # Follow-on biologics : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007.
    .

<http://www.worldcat.org/oclc/464618706>
    a schema:CreativeWork ;
    rdfs:label "Follow-on biologics" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/272403831> ; # Follow-on biologics : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007.
    .

<http://www.worldcat.org/oclc/657449220>
    a schema:CreativeWork ;
    rdfs:label "Follow-on biologics." ;
    schema:description "Online version:" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/272403831> ; # Follow-on biologics : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007.
    .

<http://www.worldcat.org/title/-/oclc/272403831>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
    schema:about <http://www.worldcat.org/oclc/272403831> ; # Follow-on biologics : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007.
    schema:dateModified "2017-09-29" ;
    void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.